Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06020248 · ClinicalTrials.gov registry record · NA

Melanin and Dermal Uptake of Thirdhand Cigarette Smoke

A NA study, sponsored by University of California, San Francisco.

Recruiting
Registry status
NA
Development phase
60
Enrollment target

NCT06020248 is a NA study that is actively recruiting participants, run by University of California, San Francisco. The registered enrollment target is 60 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06020248, a NA study, is actively recruiting participants, sponsored by University of California, San Francisco.

RECRUITING
Registry status
NA
Development phase
60 participants
Enrollment target

Study Summary

This is a pilot study of the effects of dermal melanin on dermal uptake and retention of nicotine. The initial hypothesis is that higher levels of dermal melanin will correlate with lower uptake and longer retention of nicotine in the skin and body.

Interventions

  • OTHER Wear clothing that has been exposed to cigarette smoke for 3 hours.

Trial Details

FieldValue
Enrollment Target 60 participants
Start Date 2023-09-01
Est. Completion 2026-11
Phase NA

What the Registry Record Tells You About NCT06020248

The ClinicalTrials.gov registry entry for NCT06020248 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, San Francisco, which has 1,713 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which Wear clothing that has been exposed to cigarette smoke for 3 hours. is the first listed.

NCT06020248 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT06020248 about?

NCT06020248 is a clinical study titled "Melanin and Dermal Uptake of Thirdhand Cigarette Smoke". This is a pilot study of the effects of dermal melanin on dermal uptake and retention of nicotine. The initial hypothesis is that higher levels of dermal melanin will correlate with lower uptake and longer retention of nicotine in the skin and body.

What is the current status of trial NCT06020248?

This trial is currently recruiting. It is a NA study. The enrollment target is 60 participants. The study started on 2023-09-01. Estimated completion is 2026-11.

What interventions are being tested in trial NCT06020248?

The interventions under investigation include: Wear clothing that has been exposed to cigarette smoke for 3 hours. (OTHER).

Who is sponsoring clinical trial NCT06020248?

This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.